Examination of Overall Treatment Effect and the Proportion Attributable to Contextual Effect in Osteoarthritis: Meta-analysis of Randomised Controlled Trials

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2016 Feb 18

PMID 26882927

Citations 76

Authors

Kun Zou

Jean Wong

Natasya Abdullah

Xi Chen

Toby Smith

Michael Doherty

Weiya Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: To examine the overall treatment effect and the proportion attributable to contextual effect (PCE) in randomised controlled trials (RCTs) of diverse treatments for osteoarthritis (OA).

Methods: We searched Medline, Embase, Central, Science Citation Index, AMED and CINAHL through October 2014, supplemented with manual search of reference lists, published meta-analyses and systematic reviews. Included were RCTs in OA comparing placebo with representative complementary, pharmacological, non-pharmacological and surgical treatments. The primary outcome was pain. Secondary outcomes were function and stiffness. The effect size (ES) of overall treatment effect and the PCE were pooled using random-effects model. Subgroup analyses and meta-regression were conducted to examine determinants of the PCE.

Results: In total, 215 trials (41 392 participants) were included. The overall treatment effect for pain ranged from the smallest with lavage (ES=0.46, 95% CI 0.24 to 0.68) to the largest with topical non-steroidal anti-inflammatory drugs (ES=1.37, 95% CI 1.19 to 1.55). On average, 75% (PCE=0.75, 95% CI 0.72 to 0.79) of pain reduction was attributable to contextual effect. It varied by treatment from 47% (PCE=0.47, 95% CI 0.32 to 0.70) for intra-articular corticosteroid to 91% (PCE=0.91, 95% CI 0.60 to 1.37) for joint lavage. Similar results were observed for function and stiffness. Treatment delivered by needle/injection and other means than oral medication, longer duration of treatment, large sample size (≥100 per arm) and public funding source were associated with increased PCE for pain reduction.

Conclusions: The majority (75%) of the overall treatment effect in OA RCTs is attributable to contextual effects rather than the specific effect of treatments. Reporting overall treatment effect and PCE, in addition to traditional ES, permits a more balanced, clinically meaningful interpretation of RCT results. This would help dispel the frequent discordance between conclusions from RCT evidence and clinical experience-the 'efficacy paradox'.

Citing Articles

Contextual effects in musculoskeletal pain: are we overlooking essential factors?.

Poulter D, Palese A, Rodeghiero L, Carlino E, Esteves J, Cook C Front Psychol. 2025; 16:1537242.

PMID: 40034938 PMC: 11872922. DOI: 10.3389/fpsyg.2025.1537242.

Sham treatment? Should it be redefined for its use in manual therapy clinical studies?.

Hage R, Demoulin C, Puentedura E, Brismee J J Man Manip Ther. 2025; 33(1):1-3.

PMID: 39785123 PMC: 11770848. DOI: 10.1080/10669817.2025.2448921.

Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA).

Eymard F, Oubaya N, Ornetti P, Sellam J, Richette P, Chevalier X BMJ Open. 2024; 14(11):e085025.

PMID: 39615889 PMC: 11624835. DOI: 10.1136/bmjopen-2024-085025.

The impact of contextual effects in exercise therapy for low back pain: a systematic review and meta-analysis.

de Roode A, Heymans M, van Lankveld W, Staal J BMC Med. 2024; 22(1):484.

PMID: 39443961 PMC: 11515505. DOI: 10.1186/s12916-024-03679-3.

Placebo and nocebo effects of percutaneous needle electrolysis and dry-needling: an intra and inter-treatment sessions analysis of a three-arm randomized double-blinded controlled trial in patients with patellar tendinopathy.

Domenech-Garcia V, Pecos-Martin D, Blasco-Abadia J, Bellosta-Lopez P, Lopez-Royo M Front Med (Lausanne). 2024; 11:1381515.

PMID: 38903823 PMC: 11187289. DOI: 10.3389/fmed.2024.1381515.

References

Walach H, Sadaghiani C, Dehm C, Bierman D . The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials--a secondary analysis. BMC Med Res Methodol. 2005; 5:26. PMC: 1201145. DOI: 10.1186/1471-2288-5-26. View

Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J . Influence of context effects on health outcomes: a systematic review. Lancet. 2001; 357(9258):757-62. DOI: 10.1016/s0140-6736(00)04169-6. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Colloca L, Lopiano L, Lanotte M, Benedetti F . Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004; 3(11):679-84. DOI: 10.1016/S1474-4422(04)00908-1. View

Lawrence R, Felson D, Helmick C, Arnold L, Choi H, Deyo R . Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008; 58(1):26-35. PMC: 3266664. DOI: 10.1002/art.23176. View

Zhang W, Robertson J, Jones A, Dieppe P, Doherty M . The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008; 67(12):1716-23. DOI: 10.1136/ard.2008.092015. View

Zhang W, Nuki G, Moskowitz R, Abramson S, Altman R, Arden N . OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010; 18(4):476-99. DOI: 10.1016/j.joca.2010.01.013. View

Wandel S, Juni P, Tendal B, Nuesch E, Villiger P, Welton N . Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010; 341:c4675. PMC: 2941572. DOI: 10.1136/bmj.c4675. View

Helmick C, Felson D, Lawrence R, Gabriel S, Hirsch R, Kwoh C . Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008; 58(1):15-25. DOI: 10.1002/art.23177. View

10.

Abhishek A, Doherty M . Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthritis Cartilage. 2013; 21(9):1229-35. DOI: 10.1016/j.joca.2013.04.018. View

11.

Walsh B, Seidman S, Sysko R, Gould M . Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002; 287(14):1840-7. DOI: 10.1001/jama.287.14.1840. View

12.

Juhl C, Lund H, Roos E, Zhang W, Christensen R . A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis. 2012; 2012:136245. PMC: 3389647. DOI: 10.1155/2012/136245. View

13.

Crow R, Gage H, Hampson S, Hart J, Kimber A, Thomas H . The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess. 1999; 3(3):1-96. View

14.

Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

15.

Hill A . Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial. Control Clin Trials. 1990; 11(2):77-9. DOI: 10.1016/0197-2456(90)90001-i. View

16.

Doherty M, Dieppe P . The "placebo" response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage. 2009; 17(10):1255-62. DOI: 10.1016/j.joca.2009.03.023. View

17.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

18.

Walach H . The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med. 2001; 7(3):213-8. DOI: 10.1089/107555301300328070. View

19.

Nuesch E, Trelle S, Reichenbach S, Rutjes A, Tschannen B, Altman D . Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ. 2010; 341:c3515. PMC: 2905513. DOI: 10.1136/bmj.c3515. View

20.

Wampold B, Minami T, Tierney S, Baskin T, Bhati K . The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol. 2005; 61(7):835-54. DOI: 10.1002/jclp.20129. View